ABT Financial Facts
Net foreign exchange loss (gain): 28.87MResearch and development: 346.32M
See Full Income Statement
Total Abbott Shareholders' Investment: 22.59B
Property and Equipment, at Cost: 12.42B
See Full Balance Sheet
Earnings History for Abbott Labs (ABT)
|
Expand Research on ABT
| Next EPS Date | 7/17/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/13  |
 |
Q113 | $0.42 | $0.41 | +$0.01 | $5.38B | $5.42B | N/A / N/A | = | +3.9% | Details |
| 4/20/11 |
|
Q111 | $0.91 | $0.90 | +$0.01 | $9.04B | $8.81B | N/A / N/A | = | -26% | Details |
| 4/18/12 |
|
Q411 | $1.03 | $0.99 | +$0.04 | $9.46B | $9.35B | $1.44 / $10.68B | = | -37.4% | Details |
| 10/20/10 |
|
Q310 | $1.05 | $1.04 | +$0.01 | N/A | N/A | N/A / N/A |  |
-28.5% | Details |
| 7/20/11 |
|
Q211 | $1.12 | $1.11 | +$0.01 | $9.62B | $9.56B | N/A / N/A | = | -28.5% | Details |
| 10/19/11 |
|
Q311 | $1.18 | $1.17 | +$0.01 | $9.82B | $9.65B | N/A / N/A | = | -27.9% | Details |
| 7/18/12 |
|
Q212 | $1.23 | $1.22 | +$0.01 | $9.81B | $9.84B | $1.23 / $9.92B | = | -43.1% | Details |
| 10/17/12 |
|
Q312 | $1.30 | $1.28 | +$0.02 | $9.77B | $9.93B | $1.30 / $9.95B | = | -47.6% | Details |
